Search

Your search keyword '"Bel, E H."' showing total 294 results

Search Constraints

Start Over You searched for: Author "Bel, E H." Remove constraint Author: "Bel, E H."
294 results on '"Bel, E H."'

Search Results

1. Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study

2. Economic impact of oral corticosteroids in severe asthmatics: a simulation study in selected European countries

3. Beliefs about vaccination and relation to COVID-19 vaccination side-effects in asthma patients.

4. Mepolizumab effectiveness in severe asthma supported by federated analysis of European SHARP data

5. Real-world effectiveness of reslizumab in patients with severe eosinophilic asthma – “first initiators” and “switchers”

6. Airway inflammation before and after bronchial thermoplasty

8. Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

9. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

10. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

13. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

15. Meta-Analysis of Genome-Wide Association Studies of Exacerbations in Children Using Long-Acting Beta-Agonists

19. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

20. OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study

21. Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study

22. EAACI position statement on asthma exacerbations and severe asthma

23. Characteristics and treatment regimens across ERS SHARP severe asthma registries

24. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study

26. Three phenotypes of adult-onset asthma

27. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

36. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

37. Treatable traits in the European U-BIOPRED adult asthma cohorts

38. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases: Review

39. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux

40. IL-17-high asthma with features of a psoriasis immunophenotype

41. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

42. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

43. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

44. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

46. 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use

47. [Letter to the Editor] 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use

48. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers

Catalog

Books, media, physical & digital resources